Point72 Europe (London) LLP Maravai Lifesciences Holdings, Inc. Transaction History
Point72 Europe (London) LLP
- $1.06 Billion
- Q1 2024
A detailed history of Point72 Europe (London) LLP transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Point72 Europe (London) LLP holds 2,200,343 shares of MRVI stock, worth $15.1 Million. This represents 1.8% of its overall portfolio holdings.
Number of Shares
2,200,343
Previous 2,604,487
15.52%
Holding current value
$15.1 Million
Previous $17.1 Million
11.82%
% of portfolio
1.8%
Previous 2.17%
Shares
4 transactions
Others Institutions Holding MRVI
# of Institutions
227Shares Held
135MCall Options Held
339KPut Options Held
148K-
Gtcr LLC21.7MShares$148 Million15.96% of portfolio
-
12 West Capital Management LP New York, NY13.2MShares$90.3 Million10.39% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$68.7 Million0.0% of portfolio
-
Braidwell LP Stamford, CT7.22MShares$49.4 Million2.02% of portfolio
-
Black Rock Inc. New York, NY6.41MShares$43.9 Million0.0% of portfolio
About MARAVAI LIFESCIENCES HOLDINGS, INC.
- Ticker MRVI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 131,540,000
- Market Cap $900M
- Description
- Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...